EINLADUNG | D+C Insights @ HELIX HUB | #2 (CLOSED)
Dierks+Company steht für Innovation in Healthcare und Life Sciences. Wir verbinden klassische juristische Beratung mit medizinischer Expertise, sowie strategischer Kompetenz und Implementierungssupport. Unser Ziel: Vordenker auf unserem Gebiet zu sein – um neue Produkte und Dienstleistungen zum Patienten zu bringen.
Dazu gehört ein Format, das Ideenaustausch und Ideenentwicklung fördert. Mit unseren „Insights-Events“ beleuchten wir aktuelle Themen im Gesundheitswesen und führen im HELIX HUB kreative Köpfe der Gesundheitswirtschaft, Wissenschaft und Politik zusammen.
Unsere Veranstaltungsreihe wird fortgesetzt und wir laden ein zum Thema:
TI - WOZU, WER UND WIE?
- Bringt die neue Gematik endlich eine vernetzte Versorgung und ein selbstbestimmtes Gesundheitsmanagement für Versicherte?
- Stichtag 1. Januar 2021 – wie realistisch ist die Umsetzung der ePA bis dahin?
- Eine für alle? Oder alle für eine? Welche ePA-Modelle werden sich durchsetzen?
Dazu entwickeln wir Antworten – beim zweiten D+C Insights mit:
Dr. Markus Leyck Dieken, Geschäftsführer der gematik Gesellschaft für Telematikanwendungen der Gesundheitskarte mbH
und
Christian Rebernik, CEO von Vivy - einem Startup, das Gesundheitsakte und persönliche Gesundlheitsassistentin kombiniert
am 09. September 2019 ab 17:30 Uhr bei uns im HELIX HUB.
Dierks+Company is bringing new solutions to patients:
On the first weekend of March, the Second Congress on Compliance in Healthcare took place in Leipzig – jointly organized by the Faculty of Medicine and the Faculty of Law of the University of Leipzig. Among the speakers was Prof. Dr. med. Dr. iur. Christian Dierks, who gave insights into the ePrivacy and GDPR regulations and the Telemedia Act.
In an interview within the framework of the Congress, Christian Dierks explains the role played by Dierks+Company in bringing new and innovative solutions faster to the market and thus to patients.
You can find the full interview, which was published in the spring issue of the Compliance Elliance Journal (CEJ) here.
At the beginning of April, over 120 delegates from the pharma supply chain gathered for the 10th Pharmaceutical Industry Network Group (PING) Conference, held for the second successive year on Brexit and in conjunction with Ethical Medicines Industry Group (EMIG).
Highlights from the conference included likely regulatory impact on medicine trading, supply chain concerns, EU database access, management of tax implications, importance of Tier 2 sponsorship and secured, continuation of businesses.
As the conference unfolded, various pharma areas were addressed, with input from leading pharma experts. One of them was experienced Germany-based Professor Dr. med. Dr. iur. Christian Dierks of Dierks+Company who provided an EU perspective, explaining how the German pharma industry saw Brexit. “The German view is that Brexit does not benefit patients, companies, etc.” he said. He gave a very warm expression of his and others’ feelings about the UK. It was very clear from his presentation that they wanted to have continued close relations. In an uplifting presentation, Christian Dierks commented, “pharma on both sides of the channel will suffer from Brexit, with or without a deal. We can mitigate these effects with resilience, pragmatism and cooperation…creating solutions that overcome regulatory burdens to focus on patient care.”
Please find more information about the conference here on the online portal EN-CPhi.CN.
Digital Health to touch: Christian Dierks is the lecturer for the module „Ethics, Legal and Compliance in Digital Health“ at the Hasso Plattner Institute
Which ethical and legal issues do digital health companies need to consider? And which regulatory system applies for Data, Devices, Diagnostics and Drugs - described as 4D Medicine? These and similar questions are addressed in the module "Ethics, Legal and Compliance in Digital Health" as part of the Master Program "Digital Health" at the joint Digital Engineering Faculty of the Hasso Plattner Institute (HPI) and the University of Potsdam (UP). The Lecturer of the module is Prof. Dr. med. Dr. jur. Christian Dierks from the Innovation Consultancy Dierks+Company. The interdisciplinary Master Program taught in the English language is aimed at medical and computer science students who want to work as highly qualified experts in the health sector at the interface between IT, computer science and medicine.
The interactive kick-off workshop for the module took place at the end of April. After a brief introduction to the topic, Christian Dierks and his team from Dierks+Company introduced the participants to the innovative working methods they would use. Among other things, the participants worked in breakout sessions on personas and a patient journey and used design thinking methods.
By using a concrete case study "Implandata", the Dierks+Company team illustrated the interfaces of 4D medicine to the participants and showed which added value Digital Health creates and which ethical and legal questions and compliance aspects have to be considered. Implandata Ophthalmic Products GmbH (IOP), a medical technology company based in Hanover, Germany, has developed a novel system that enables the continuous measurement of intraocular pressure in glaucoma patients. In this way, the disease can be monitored and the patients can be protected from blindness. This novel diagnostic tool can be used telemedically, so that frequent visits to the doctor are no longer absolutely necessary. The CEO of Implandata, Max G. Ostermeier, was present himself and demonstrated the product, a sensor for continuous measurement of intraocular pressure as well as a device for reading out the data - digital health to touch, so to speak.
The next session took place the day after on the topics of Data - GDPR and Data Security. In the course of the semester, 3 further sessions on Compliance, Devices and Artificial Intelligence will follow. More about the Digital Health course at HPI and the module can be found here on the HPI website.
Dierks+Company is the Innovation Consultancy for Healthcare and Life Sciences in Berlin. It supports the development and establishment of products and services in 4D-medicine (Drugs, Devices, Diagnostics and Data). The lawyers and the consultancy team merge legal-medical competence with strategic consulting and support in the implementation. This way it helps German and international companies to overcome regulatory barriers and place products in Germany as a key market. HELIX HUB is the headquarter of Dierks+Company and at the same time a co-working space. On 3.300 m² it has a lot of room for synergies with clients, startups and companies in the field of health care.
Normalerweise schreiben wir an dieser Stelle über neue Verordnungen, Expertenforen oder Erfolge, die wir für unsere Mandanten erringen konnten. Doch was uns in der letzten Zeit am meisten bewegt hat, war natürlich die Eröffnung von Dierks+Company im Helix Hub, unserem Gebäude in Berlin Mitte.
Wir haben Freunde, Geschäftspartner und Vertreter von Wissenschaft und Gesundheitspolitik eingeladen, ein Gast machte sogar eine Zwischenlandung auf seinem Weg von L.A. nach Tel Aviv, um dabei zu sein. Es gab eine coole Jazz-Band, ein befreundeter Koch übernahm das Catering und die ganze wunderbare Gesellschaft wurde total analog mit Stift und Papier von den Zeichnern festgehalten. Die Tournee durch das Gebäude mit den Präsentationen der Unternehmen machte uns allen deutlich, welche enormen Potenziale in der Innovation der Medizin stecken. Und die blau leuchtende Bar auf der Terrasse hatte ganz offensichtlich magische Kräfte.
Weit nach Mitternacht schlossen wir schließlich – glücklich und erfüllt – die Tür des Helix Hub hinter uns, um am nächsten Tag wieder auf der Matte zu stehen.
Das Fest wirkt immer noch nach. Viele Gespräche und Begegnungen haben wir in lebhafter Erinnerung, viele Anregungen und Eindrücke bleiben erhalten. Und ein Gedanke blieb besonders hängen: Wir brauchen ja nicht immer eine Eröffnung für ein Fest!
Impressionen dieses ganz besonderen Abends finden Sie hier:
